RespireRx Pharmaceuticals Inc (RSPI)

[food4thought]

Aiming,
I'm past the whole issue, but I am just saying that if Stoll had been given a reason from the FDA on Oct 11th then why has he not been more forthcoming regarding the reasoning?

If he didn't withdraw the IND then he most certainly, as you have said, asked and received a reasonable response via phone or whatever to justify the rejection. I doubt the FDA said "your IND was not accepted, we will send you a letter as to why", and Stoll said "ok thanks it was worth a try".

I am certainly not trying to rehash all this, it would just be nice to know the exact reason as to our current situation. If Stoll was so eager to move on then it just seems he knew the possiblity was there for FDA rejection due to an artifact or whatever. That indicates dishonest behavior for he did exclaim at the CC to inform the post mortem conclusion that the compound was clean and there should be no problems that he had foreseen to aquire FDA approval.